CUOMO, ROSARIO
 Distribuzione geografica
Continente #
NA - Nord America 14.036
AS - Asia 12.763
EU - Europa 9.353
SA - Sud America 1.666
Continente sconosciuto - Info sul continente non disponibili 492
AF - Africa 306
OC - Oceania 93
Totale 38.709
Nazione #
US - Stati Uniti d'America 13.485
SG - Singapore 5.798
RU - Federazione Russa 3.657
CN - Cina 2.238
VN - Vietnam 2.006
IT - Italia 1.596
BR - Brasile 1.343
HK - Hong Kong 1.140
UA - Ucraina 767
DE - Germania 675
FR - Francia 618
FI - Finlandia 468
IE - Irlanda 390
GB - Regno Unito 322
IN - India 319
JP - Giappone 263
CA - Canada 256
SE - Svezia 233
NL - Olanda 230
BD - Bangladesh 211
MX - Messico 167
AR - Argentina 115
PL - Polonia 96
TR - Turchia 91
ES - Italia 85
PH - Filippine 84
ZA - Sudafrica 84
AU - Australia 80
IQ - Iraq 80
ID - Indonesia 78
EC - Ecuador 63
TH - Thailandia 58
CI - Costa d'Avorio 57
PK - Pakistan 56
CO - Colombia 49
TW - Taiwan 41
SA - Arabia Saudita 40
KR - Corea 39
VE - Venezuela 30
AT - Austria 29
BE - Belgio 29
JM - Giamaica 26
JO - Giordania 24
MA - Marocco 24
MY - Malesia 23
EG - Egitto 21
LT - Lituania 21
ET - Etiopia 20
NP - Nepal 20
IL - Israele 19
KE - Kenya 19
CL - Cile 18
DZ - Algeria 18
LB - Libano 18
UZ - Uzbekistan 18
CR - Costa Rica 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
AZ - Azerbaigian 15
IR - Iran 15
PY - Paraguay 14
BO - Bolivia 13
GR - Grecia 13
NZ - Nuova Zelanda 13
RS - Serbia 13
PT - Portogallo 12
TT - Trinidad e Tobago 12
AE - Emirati Arabi Uniti 11
EU - Europa 11
HN - Honduras 11
PE - Perù 11
DK - Danimarca 10
RO - Romania 10
GT - Guatemala 9
DO - Repubblica Dominicana 8
NI - Nicaragua 8
PA - Panama 8
KZ - Kazakistan 7
OM - Oman 7
AO - Angola 6
BB - Barbados 6
LK - Sri Lanka 6
UY - Uruguay 6
AL - Albania 5
CH - Svizzera 5
HR - Croazia 5
HU - Ungheria 5
KG - Kirghizistan 5
PR - Porto Rico 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
SV - El Salvador 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
KW - Kuwait 4
MD - Moldavia 4
MK - Macedonia 4
MT - Malta 4
Totale 38.138
Città #
Singapore 2.583
San Jose 1.415
Hong Kong 1.102
Moscow 945
Chandler 822
Jacksonville 811
Ashburn 700
Beijing 569
Ho Chi Minh City 498
Santa Clara 496
Hanoi 453
Millbury 442
Princeton 393
The Dalles 343
Lauterbourg 341
Los Angeles 309
Nanjing 277
Napoli 234
Tokyo 220
Buffalo 198
Wilmington 197
Boston 187
Naples 187
New York 182
Woodbridge 176
Dallas 173
Amsterdam 167
Council Bluffs 158
Munich 131
São Paulo 122
Dearborn 103
Ann Arbor 102
Atlanta 101
Dong Ket 100
Houston 99
Kronberg 92
Ottawa 90
Da Nang 89
Nanchang 86
Milan 81
Haiphong 74
Orem 74
Redondo Beach 74
Shenyang 72
Denver 71
Hefei 71
Des Moines 70
Seattle 70
Mexico City 69
Hebei 68
Frankfurt am Main 64
San Francisco 64
Warsaw 63
London 60
Rome 59
Boardman 54
Changsha 53
Montreal 53
Norwalk 52
Tianjin 49
Chicago 47
Brooklyn 46
Mumbai 46
Jiaxing 45
Phoenix 45
Turku 44
Falls Church 43
Hải Dương 37
Chennai 36
Helsinki 34
Rio de Janeiro 34
Baghdad 32
Bangkok 32
Johannesburg 32
Shanghai 32
Belo Horizonte 31
Falkenstein 30
Melbourne 30
Pune 29
Quito 29
Stockholm 29
Biên Hòa 27
Dublin 27
Toronto 27
Brasília 26
Guangzhou 26
Redwood City 26
Nuremberg 25
Orange 25
Curitiba 24
Jakarta 24
Poplar 24
Thái Nguyên 22
Amman 21
Kunming 21
Can Tho 20
Indiana 20
Gateshead 19
Addis Ababa 18
Brussels 18
Totale 18.261
Nome #
Effects of oral supplementation with the symbiotic (bifidobacterium longum w11 + fos actilight) on IBS with constipation: a randomized, dose finding trial, versus fibers, 620
Effects of carbonated water on functional dyspepsia and constipation. 501
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 491
Postprandial Gastrointestinal Function Differs after Acute Administration of Sourdough Compared with Brewer's Yeast Bakery Products in Healthy Adults 470
La dispepsia post-infettiva: evoluzione sintomatologica- funzionale, predisposizione genetica, ruolo dell'Ossido Nitrico Sintetasi inducibile e coinvolgimento della glia entererica. 366
Effect of carbonated drinks on upper digestive tract sensations and physiology in healthy subjects. 362
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. 323
Altered taste perception in patients with gastroesophagealreflux disease 259
Italian guidelines for the diagnosis and management of colonic diverticulosis and diverticular disease 254
Frequency, Symptoms Evolution and Pathophysiological Correlates in Prospectively Identified Patients With Postinfectious Dyspepsia 229
ADHERENCE TO MEDITERRANEAN DIET AND IBS SYMPTOMS IN ADOLESCENTS 229
Mild dehydration in dyspeptic athletes is able to increase gastrointestinal symptoms: Protective effects of an appropriate hydration 224
ALLELE-SPECIFIC TRANSCRIPTIONAL ACTIVITY OF THE VARIABLE NUMBER OF TANDEM REPEATS OF THE INDUCIBLE NITRIC OXIDE SYNTHASE GENE IS ASSOCIATED WITH IDIOPATHIC ACHALASIA 202
Sleeve gastrectomy-induced weight loss in severe obesity did not modify perception, intensity and pleasantness of basic tastes 197
Role of Non-Caloric Carbonated Beverage Preload During a Standardized Solid and Liquid Meal on Colecistokinin and Ghrelin Levels in Healthy Subjects 180
Effects of long-term PPI treatment on producing bowel symptoms and SIBO 177
Carbonated beverages and gastrointestinal system: between myth and reality 173
Enteric Glia Stimulates Inflammation-Induced Responses in Human Intestine and Interacts with Immune Cells via S100B Protein 169
Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects ofL. casei DG® (Lactobacillus paracaseiCNCM I-1572) 168
SPECIFIC DYSPEPTIC SYMPTOMS ARE ASSOCIATED WITH POOR RESPONSE TO THERAPY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 166
Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis. 161
The astroglial-derived S100 Beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. 160
Eosinophilic esophagitis: From pathophysiology to treatment. 160
EARLY CHANGES IN HRM-OESOPHAGEAL PARAMETERS IN PRE AND POST TREATMENT ACHALASIA PATIENTS 158
Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index 156
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 155
Probiotic and Postbiotic Effects of Lactobacillus Casei DG on Enteroglial-Derived S100B and Nitric Oxide Production in Human Intestinal Biopsies 154
Diagnosis and Treatment of Multiple Intestinal Angioectasias: A Case Report 153
CHRONIC CONSTIPATION IS A RISK FACTOR FOR METABOLIC SYNDROME 152
PHENYLTHIOCARBAMIDE TASTING STATUS AFFECTS QUININE-MEDIATED REDUCTION OF FOOD INTAKE 151
Quality of bowel cleansing in hospetalized patients undergoing colonoscopy: a multicenter prospective regional study 150
Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88 /NF-?B pathway 150
S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. 148
TASTE DISORDERS IN PATIENTS WITH GASTROESOPHAGEALREFLUX DISEASE 148
Esofago di Barrett 148
Epidemiology and societal costs of gastroesophageal reflux disease and Barrett's syndrome in Germany, Italy and Spain 147
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 147
CO2 Modulates the Central Neural Processing of Sucrose Perception 147
Impaired post-reflux swallow-induced peristaltic wave in severe obesity and implication in esophageal hyposensitivity 145
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders 144
Body position may change high resolution manometry parameters and drift therapeutic choice in achalasia patients 144
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 144
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 144
ACETONIC EXTRACT FROM FEIJOA SELLOWIANA BERG.FRUITS INHIBITS PROLIFERATION, MODULATES BRUSH BORDERMEMBRANE ENZYMES ACTIVITIES AND PREVENT LIPID PEROXIDATIONIN HUMAN INTESTINAL EPITHELIAL CELLS 143
Medical treatment of gastro-oesophageal reflux disease. 142
Acetonic Extract from the Feijoa sellowiana Berg. Fruit Exerts Antioxidant Properties and Modulates Disaccharidases Activities in Human Intestinal Epithelial Cells 141
The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects 141
Effect of enteroglial-derived S100B protein on human peripheral and mucosal immune cells’ functions 140
Esophageal sensitivity and impaired post-reflux swallow-induced peristaltic wave are dependent by body mass index and acid exposition 140
Iron Absorption following a Single Oral Dose of Ferrous Sulfate or Ferric Gluconate in Patients with Gastrectomy 139
GERD IS A PROTECTIVE RISK FACTOR FOR HYPERTENSION 138
Pathophysiology of gastro-oesophageal reflux disease. 137
Esophageal Acid Exposure and Altered Neurocardiac Function in Patients with GERD and Idiopatic Cardiac Arrhythmias 137
ACHALASIA TREATMENT IMPROVES SPECIFIC SYMPTOMS AND QUALITY OF LIFE: VALIDATION OF AN ACHALASIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE 137
Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013 137
DOES STANDARDIZED DIET IMPROVE PROTON PUMP INHIBITOR RESPONSE IN GERD PATIENTS? 136
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 135
BITTER TASTE RECEPTOR AGONIST AFFECTS FOOD INTAKEIN HEALTHY SUBJECTS 135
Gastroesophageal reflux disease (GERD) cost of care: Role of naive and relapsed symptoms in general practice 134
La proteina di derivazione enterogliale S100B stimola la produzione di ossido nitrico nella colite ulcerosa. 134
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 134
A patient with oeosinophilic gastroenteritis and severe malnutrition improved with home parenteral nutrition 134
Impaired Enterohormone Response Following a Liquid Test Meal in Gastrectomized Patients 134
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner 133
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 133
Cortical representation of different taste modalities on the gustatory cortex: A pilot study 133
THE MEDITERRANEAN DIET IS A PROTECTIVE FACTOR AGAINST GASTROINTESTINAL SYMPTOMS IN YOUNG PEOPLE 132
CORRELATES TO ABDOMINAL PAIN IN CONSTIPATION PREVALENT IBS PATIENTS 132
CO2 modulates the central neural processing of sweet perception: an fMRI study 132
Enteric glia: A new player in inflammatory bowel diseases 132
Enteric Glial Protein S100b Up-Regulation Stimulates Nitric Oxide Production in Ulcerative Colitis. 131
6 months-treatment of symptomatic uncomplicated diverticular disease of the colon with Lactobacillus paracasei F19 131
Effect of enteroglial-derived S100B protein on proliferation and responses in human peripheral and mucosal immune cells 131
THE ENTEROGLIAL DERIVED-S100B PROTEIN MEDIATES THEPROTECTIVE EFFECT OF LACTOBACILLUS CASEI DG ON LPS-INDUCEDNITRIC OXIDE PRODUCTION IN HUMAN INTESTINAL BIOPSIES 131
Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease 131
The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples 129
Autoimmune comorbidities in idiopathic achalasia 129
PARTIALLY HYDROLYZED GUAR GUM (PHGG) IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH CONSTIPATION: EFFECTS OF GENDER, AGE AND BODY MASS INDEX (BMI) 128
Genetic contribution to motility disorders of the upper gastrointestinal tract. 128
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. 127
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 126
Mechanisms underlying duodeno-gastric reflux in man. 125
Proton pump inhibitors prescribing following the introduction of generic drugs 125
Association between ccttt pentanucleotide repeat in the inducible nitric oxide synthase promoter polymorphism and achalasia 124
Irritable bowel syndrome and food interaction. 124
Influence of generic drugs on proton pump inhibitor prescription in primary care. 123
The role of a pre-load beverage on gastric volume and food intake: comparison between non-caloric carbonated andnon-carbonated beverage 123
Proton pump inhibitors market in primary care setting. 123
THE ENTEROGLIAL-DERIVED S100B PROTEIN CONTROLSHUMAN INTESTINAL EPITHELIAL CELLS DIFFERENTIATION ANDPROLIFERATION VIA RAGE INTERACTION 123
Role of Human Enteroglial Cells in Mediating Pathogenic and Probiotic Bacteria Effects on Intestinal Epithelial Cells 122
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 121
Gastric determinants of maximum satiety induced by standardized solid and liquid meal. An MRI study in non obese healthy subjects 121
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 121
PRESENCE OF ATYPICAL AND PAINFUL SYMPTOMS CORRELATES WITH LOW BMI AND POOR QUALITY OF LIFE IN GERD PATIENTS 121
Dyspeptic symptoms improvement in patients with non-erosive reflux disease is correlated with the degree of intragastric acid inhibition. 119
IRON ABSORPTION AFTER SINGLE ORAL DOSE OF FERROUS SULFATE OR FERRIC GLUCONATE IN PATIENTS WITH TOTAL GASTRECTOMY: PRELIMINARY DATA 119
TASTE ALTERATIONS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 119
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-activation. 119
Molecular Signaling and Dysfunction of the Human Reactive Enteric Glial Cell Phenotype: Implications for GI Infection, IBD, POI, Neurological, Motility, and GI Disorders 119
CORRELATION BETWEEN HIGH RESOLUTION MANOMETRY PARAMETERS AND SYMPTOMS IN TREATED ACHALASIA PATIENTS 118
Totale 16.632
Categoria #
all - tutte 124.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.981 0 11 9 10 22 115 26 72 404 79 420 813
2022/20232.025 420 143 37 160 227 235 20 190 289 172 101 31
2023/20241.588 39 209 164 114 66 117 58 210 39 52 341 179
2024/20259.021 552 663 46 94 257 423 839 509 1.089 861 2.836 852
2025/202615.840 1.926 939 1.461 1.345 2.616 648 1.586 1.098 2.085 1.158 391 587
2026/20272.530 1.949 581 0 0 0 0 0 0 0 0 0 0
Totale 38.709